Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-F Chen

Showing results (41-50 of 452) with videos related to

Pageof 46
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|November 15, 2012
Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitusNelson K F Chen, Tsung Wen Chong, Hwai-Liang Loh, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2006
Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acneW Chen, C C Yang, C Y Liao, et al.
Oncogene|February 16, 2016
Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potentialM-H Hung, Y-L Chen, P-Y Chu, et al.
Cell Death & Disease|February 9, 2013
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cellsW-T Tai, C-W Shiau, H-L Chen, et al.
Oncogene|August 24, 2010
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsK-F Chen, C-Y Liu, Y-C Lin, et al.
Oncogene|July 18, 2017
SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinomaL-C Fan, C-W Shiau, W-T Tai, et al.
Oncogene|January 27, 2015
SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinomaL-C Fan, C-W Shiau, W-T Tai, et al.
Cell Death & Disease|August 1, 2014
Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2AH-C Yu, M-H Hung, Y-L Chen, et al.
Neoplasma|May 11, 2020
Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinomaM M Chen, R C Zhao, K F Chen, et al.
Plos One|March 6, 2008
Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical modelNelson K F Chen, Jen San Wong, Irene H C Kee, et al.
Pageof 46

Showing results (41-50 of 452) with videos related to

Sort By:
Pageof 46
Journal of Molecular Medicine (Berlin, Germany)|November 15, 2012
Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitusNelson K F Chen, Tsung Wen Chong, Hwai-Liang Loh, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2006
Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acneW Chen, C C Yang, C Y Liao, et al.
Oncogene|February 16, 2016
Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potentialM-H Hung, Y-L Chen, P-Y Chu, et al.
Cell Death & Disease|February 9, 2013
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cellsW-T Tai, C-W Shiau, H-L Chen, et al.
Oncogene|August 24, 2010
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsK-F Chen, C-Y Liu, Y-C Lin, et al.
Oncogene|July 18, 2017
SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinomaL-C Fan, C-W Shiau, W-T Tai, et al.
Oncogene|January 27, 2015
SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinomaL-C Fan, C-W Shiau, W-T Tai, et al.
Cell Death & Disease|August 1, 2014
Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2AH-C Yu, M-H Hung, Y-L Chen, et al.
Neoplasma|May 11, 2020
Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinomaM M Chen, R C Zhao, K F Chen, et al.
Plos One|March 6, 2008
Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical modelNelson K F Chen, Jen San Wong, Irene H C Kee, et al.
Pageof 46